Drug Target Review Assays ebook 2021
Posted: 22 September 2021 | Drug Target Review | No comments yet
Included in this ebook are articles exploring the discovery of therapeutics that can be repurposed against COVID-19 and discussing a novel assay approach for the identification of drug targets using mass spectrometry.
Novel approaches to inhibit SARS-CoV-2 remain a focus of research. Professor Christopher Basler reveals how a collaborative effort used new assays to identify drugs that can be repurposed against COVID-19, by targeting proteins involved in fatty acid metabolism.
In another article, Professor Forest White and Dr Lauren Stopfer explore an innovative method to identify potential therapeutic targets using mass spectrometry. They explain how this assay can be used from sample preparation to monitoring and quantitation of target peptides.
Included in this ebook:
Drug Target Review has just announced the launch of its NEW and EXCLUSIVE report examining the evolution of AI and informatics in drug discovery and development.
In this 63 page in-depth report, experts and researchers explore the key benefits of AI and informatics processes, reveal where the challenges lie for the implementation of AI and how they see the use of these technologies streamlining workflows in the future.
Also featured are exclusive interviews with leading scientists from AstraZeneca, Auransa, PolarisQB and Chalmers University of Technology.
- Targeting SARS-CoV-2 replication with inhibitors of lipid metabolism
Professor Christopher Basler, Georgia State University - Improving drug discovery with advanced targeted proteomic monitoring workflows
Professor Forest White, MIT
Dr Lauren Stopfer, BioNTech
